These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 19183379

  • 1. Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck.
    Farhadieh RD, Smee R, Rees CG, Salardini A, Eggleton S, Yang JL, Russell PJ.
    ANZ J Surg; 2009; 79(1-2):48-54. PubMed ID: 19183379
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma.
    Homann N, Nees M, Conradt C, Dietz A, Weidauer H, Maier H, Bosch FX.
    Clin Cancer Res; 2001 Feb; 7(2):290-6. PubMed ID: 11234882
    [Abstract] [Full Text] [Related]

  • 3. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Nathan CO, Amirghahri N, Rice C, Abreo FW, Shi R, Stucker FJ.
    Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
    [Abstract] [Full Text] [Related]

  • 4. Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing.
    Tokumaru Y, Yamashita K, Osada M, Nomoto S, Sun DI, Xiao Y, Hoque MO, Westra WH, Califano JA, Sidransky D.
    Cancer Res; 2004 Sep 01; 64(17):5982-7. PubMed ID: 15342377
    [Abstract] [Full Text] [Related]

  • 5. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E, Peschos D, Goussia A, Mittari E, Charalabopoulos K, Michael M, Salmas M, Vougiouklakis T, Assimakopoulos D, Agnantis NJ.
    J Exp Clin Cancer Res; 2004 Jun 01; 23(2):277-83. PubMed ID: 15354413
    [Abstract] [Full Text] [Related]

  • 6. Head and neck squamous cell carcinoma in non-smoking and non-drinking patients with multiple tumors: etiologic significance of p53 and Ki-67 in non-tumorous epithelium.
    Farshadpour F, Hordijk GJ, Koole R, Slootweg PJ.
    J Oral Pathol Med; 2008 Oct 01; 37(9):549-54. PubMed ID: 18331287
    [Abstract] [Full Text] [Related]

  • 7. Nuclear expression of maspin is associated with a lower recurrence rate and a longer disease-free interval after surgery for squamous cell carcinoma of the larynx.
    Marioni G, Blandamura S, Giacomelli L, Calgaro N, Segato P, Leo G, Fischetto D, Staffieri A, de Filippis C.
    Histopathology; 2005 May 01; 46(5):576-82. PubMed ID: 15842640
    [Abstract] [Full Text] [Related]

  • 8. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
    Rodrigo JP, García-Carracedo D, García LA, Menéndez S, Allonca E, González MV, Fresno MF, Suárez C, García-Pedrero JM.
    J Pathol; 2009 Mar 01; 217(4):516-23. PubMed ID: 18991334
    [Abstract] [Full Text] [Related]

  • 9. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
    Garozzo A, Cutrona D, Palmeri S, Maiolino L, Puzzo L, Allegra E.
    Acta Otorhinolaryngol Ital; 1999 Dec 01; 19(6):342-7. PubMed ID: 10875157
    [Abstract] [Full Text] [Related]

  • 10. Clinical significance of c-myc and p53 expression in head and neck squamous cell carcinomas.
    Waitzberg AF, Nonogaki S, Nishimoto IN, Kowalski LP, Miguel RE, Brentani RR, Brentani MM.
    Cancer Detect Prev; 2004 Dec 01; 28(3):178-86. PubMed ID: 15225897
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question.
    Cabanillas R, Rodrigo JP, Astudillo A, Domínguez F, Suárez C, Chiara MD.
    Cancer; 2007 May 01; 109(9):1791-8. PubMed ID: 17380529
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.
    Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A.
    Cancer Res; 1995 Mar 01; 55(5):975-8. PubMed ID: 7867006
    [Abstract] [Full Text] [Related]

  • 14. Correlation between the expression of cyclin A protein and p53 activity in oral squamous cell carcinomas.
    Chen Q, Zhou H, Guo W, Samaranayake LP, Zhou M, Li B.
    Cytobios; 2001 Mar 01; 106(412):87-99. PubMed ID: 11503976
    [Abstract] [Full Text] [Related]

  • 15. Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell.
    Takes RP, Baatenburg de Jong RJ, Schuuring E, Litvinov SV, Hermans J, Van Krieken JH.
    Anticancer Res; 1998 Mar 01; 18(6B):4793-800. PubMed ID: 9891559
    [Abstract] [Full Text] [Related]

  • 16. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
    Vielba R, Bilbao J, Ispizua A, Zabalza I, Alfaro J, Rezola R, Moreno E, Elorriaga J, Alonso I, Baroja A, de la Hoz C.
    Laryngoscope; 2003 Jan 01; 113(1):167-72. PubMed ID: 12514403
    [Abstract] [Full Text] [Related]

  • 17. [Correlation between expression of p53 and prognosis of laryngeal squamous carcinoma].
    Xia LP, Zeng ZY, Guo ZM, Rao HL, Zeng J, Xu GP, Zhang Q.
    Ai Zheng; 2003 Jan 01; 22(1):77-82. PubMed ID: 12561442
    [Abstract] [Full Text] [Related]

  • 18. p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck.
    Henriksson E, Baldetorp B, Borg A, Kjellen E, Akervall J, Wennerberg J, Wahlberg P.
    Acta Oncol; 2006 Jan 01; 45(3):300-5. PubMed ID: 16644573
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck.
    Fouret P, Temam S, Charlotte F, Lacau-St-Guily J.
    Br J Cancer; 2002 Dec 02; 87(12):1390-5. PubMed ID: 12454767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.